Skip to main content

View full-text article in PMC

. 2021 Mar 3;8(1):e22944. doi: 10.2196/22944

Table 3.

Secondary outcome assessment 5-level 5-dimension quality of life measure.

Time periods		Intervention		Control		Difference
		Mean (SD)	n (%)	Mean (SD)	n (%)	d (95% CI)	P value
Baseline/preadmission^a
	Index	0.64 (0.19)	47 (100)	0.59 (0.21)	47 (100)	0.05 (−0.03 to 0.14)	.20
	VAS^b	64.79 (20.02)	47 (100)	68.55 (18.23)	47 (100)	−3.77 (−11.62 to 4.09)	.34
Change baseline—6 weeks^a
	Index	0.17 (0.20)	37 (95)	0.19 (0.26)	42 (98)	−0.02 (−0.12 to 0.09)	.77
	VAS	10.43 (15.05)	37 (95)	10.52 (15.73)	42 (98)	−0.09 (−7.01 to 6.83)	.98
Change baseline—3 months^a
	Index	0.21 (0.21)	40 (95)	0.23 (0.21)	37 (100)	−0.02 (−0.11 to 0.08)	.72
	VAS	12.82 (20.08)	39 (93)	9.76 (15.05)	37 (100)	3.06 (−5.08 to 11.21)	.46
Change baseline—6 months^a
	Index	0.22 (0.18)	32 (97)	0.27 (0.22)	39 (100)	−0.05 (−0.15 to 0.05)	.29
	VAS	15.77 (16.90^c)	31 (94)	13.23 (13.21)	39 (100)	2.54 (−4.63 to 9.72)	.48

^aIndependent t test.

^bVAS: visual analogue scale.

^cLarge outlier (−62)—intervention participant (ID#51) not included.